PPBP and nonpapillary renal cell carcinoma: Chemokine CXCL7 produced by neutrophils in ccRCC is a risk factor for tumor progression and has been proven to be an effective marker for first-line therapy of metastatic ccRCC with sunitinib in plasma [106].